Click here to go to the previous page
Program Code:
PD-3
Date:
Tuesday, October 30, 2007
ABSTRACT PRESENTER(S):
Sung-Ja Ahn, M.D., Chonnam National University Hwasun Hospital, Hwasun 160, Republic of Korea
Jessamy Boyd, M.D., Duke University, Durham, NC
Abhay Gokhale, M.D., University of Pittsburgh Cancer Institute, Pittsburgh, PA
Inga Grills, M.D., William Beaumont Hospital, Royal Oak, MI
Justin Hart, M.D., Ph.D., University of Texas, M.D. Anderson Cancer Center, Houston, TX
Jessica Hubbs, Department of Radiation Oncology, Duke University Medical Center, Durham, NC
Justin Juliano, M.D., Cleveland Clinic, Cleveland, OH
Zhongxing Liao,
M.D., Professor,
The University of Texas M.D. Anderson Cancer Center, Houston, TX
After completion residency training in 1999, I joined the faculty as an Assistant Professor in the Section of Thoracic Radiation Oncology in the Department of Radiation Oncology. Since then, I have focused my career in patient care, translational research, education, and administrative leadership. In 2002, I was appointed Clinical Chief of the Section of Thoracic Radiation Oncology. In September 2004, I was promoted to Associate Professor (NTCA) of Radiation Oncology. In January 2007, I was appointed Center Medical Director, Department of Radiation Oncology, in the Division of Radiation Oncology. Through my efforts in clinical care, research and leadership I have contributed to our institutional mission and been able to positively impact the care of patients with lung cancer and patients with esophageal cancer.
My research focus aim is to improve therapeutic ratio of radiation therapy for thoracic malignancies through translational research. More specifically, I seek to improve the efficacy and reduce the toxicity of chemoradiation therapy for lung and esophageal cancers by using molecular targeting strategies; by using advanced radiation delivery technologies; by generating and using models for predicting risks of normal tissue toxicity; by reducing that toxicity with adaptive modification of radiation parameters based on biomarkers such as single nucleotide polymorphisms and serum levels of inflammatory cytokines, by reducing the symptom burden and improving patients quality of life using integrative medicine, and ultimately, by developing strategies to practice highly personalized treatments.
|
Jinli Ma, M.D., Department of Radiation Oncology, Duke University Medical Center, Durham, NC
I am a Radiation Oncologist with a strong interest in clinical and translational research. After initial training in Internal Medicine and Clinical Oncology the UK, I spent two years on the Faculty at the Department of Radiation Oncology at Stanford University|University before taking up my current position as Radiation Oncologist at Peter MacCallum Cancer Centre. I am an Associate Professor at the |University of Melbourne and Chair the RANZCR Research Committee in Radiation Oncology. One of my major interests has been the role of PET scanning in patients who are candidates for Radiation Therapy. In collaboration with my colleague Professor Rod Hicks I have been involved in some of the first prospective studies of PET in Radiation Oncology and together we have published many papers on this topic. Current interests include RT planning using FDG-PET and studying changes in FLT uptake during the course of RT. Recent publications concern the role of FDG-PET in staging lung cancer, response assessment after chemo RT and the role of PET in RT planning. I am a member of the IAEA group that has studied PET in RT planning and we hope that our report will be published in the near future.
|
Robert McCammon, M.D., University of Colorado Health Sciences Ctr., Aurora, CO
Susan McGovern, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX
Sarah McGuire, Ph.D., Duke University Medical Center, Durham, NC
Subhakar Mutyala, M.D., Montefiore Medical Center, Bronx, NY
Ashish Patel, M.D., University of Maryland, Baltimore, MD
Yoshiyuki Shioyama, M.D., Ph.D., Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka City, Japan
MODERATOR(S):
Indrin Julian Chetty, PhD, Henry Ford Hospital and Health Centers
Mitchell Machtay, M.D., University Hospitals Case Medical Center/ Case Western Reserve University